title: First-to-invent versus first-to-file: impact of the AIA.
abstract: On March 16, 2013, the USPTO switched from a 'first-to-invent' to a 'first-to-file' patent system. Under the 2011 America Invents Act, patents will be awarded to the first inventor to file a patent application as opposed to the date of invention. Now, over a year since the main provisions of the America Invents Act (AIA) came into effect, Pharmaceutical Patent Analyst has invited a selection of IP specialists and researchers from the US to discuss the implications of this new law and how it will affect future pharmaceutical and medical R&D. Interview conducted by Alexandra Sklan, Commissioning Editor.
authors.forename: Tara
authors.initials: T
authors.lastname: Rachinsky
authors.forename: Clark
authors.initials: C
authors.lastname: Sullivan
authors.forename: Shubha
authors.initials: S
authors.lastname: Ghosh
authors.forename: David S
authors.initials: DS
authors.lastname: Resnick
authors.forename: Carlyn
authors.initials: C
authors.lastname: Burton
authors.forename: MaryAnne
authors.initials: M
authors.lastname: Armstrong
authors.forename: John P
authors.initials: JP
authors.lastname: Hanish
authors.forename: Alexandra
authors.initials: A
authors.lastname: Sklan
mesh_terms: D055808:Drug Discovery; D004345:Drug Industry / Q000331:legislation & jurisprudence*; D005060:Europe; D007878:Legislation as Topic; D010330:Patents as Topic / Q000331:legislation & jurisprudence*; D012106:Research; D014481:United States